Georg Aue, Margaret A. Lindorfer, Paul V. Beum, Andrew W. Pawluczkowycz, Berengere Vire, Thomas Hughes, Ronald P. Taylor, and Adrian Wiestner. 2010. “Fractionated Subcutaneous Rituximab Is Well-Tolerated and Preserves CD20 Expression on Tumor Cells in Patients With Chronic Lymphocytic Leukemia”. Haematologica 95 (2). Pavia, Italy, 329-32. https://doi.org/10.3324/haematol.2009.012484.